MA v Lindsay Clancy - Dr. Jennifer Tufts - BOTH DAYS

Dr. Jennifer Tufts provides a detailed clinical chronicle of her treatment of Lindsay Clancy, one of her first patients after being independently licensed, between September 2022 and January 23, 2023. Clinical Background and Initial Evaluation (September 2022) • Provider Role & Context: Dr. Tufts, a licensed psychiatrist at Aster Mental Health, conducted a total of 14 visits with Lindsay Clancy starting in mid-September 2022. • Intake Assessment & History: Prior to her first session, Clancy completed extensive intake questionnaires. She reported a history of brief, side-effect-free Prozac and Wellbutrin use during nursing school, moderate alcohol consumption, and no history of abuse. • Symptom Checklist: She reported experiencing anxiety attacks, depressed mood, decreased appetite, easily distracted states, excessive worry, guilt, racing thoughts, an inability to feel pleasure, and sleep difficulties. Notably, she checked "no" to all safety-related questions, denying suicidal thoughts, homicidal ideation, and auditory/visual hallucinations. • Diagnoses & Initial Plan: Dr. Tufts diagnosed her with Generalized Anxiety Disorder (GAD) and Adjustment Disorder with Depressed Mood. The initial treatment plan recommended individual therapy and a low dose (25 mg) of Sertraline (Zoloft). Medication Apprehension and Early Adjustments (September–November 2022) • Reluctance & "Poor Insight": Clancy was highly anxious about medication side effects and initially decided not to take the Zoloft. Dr. Tufts noted Clancy's insight was "poor" because she resisted pharmacological treatment despite exhibiting clinically significant anxiety. • Brief Zoloft Trial: In mid-October, Clancy finally tried the Zoloft but stopped after a week when increasing to 50 mg made her feel "awful," causing increased insomnia, loss of appetite, diarrhea, brain fog, and heightened anxiety. Introduction of As-Needed Medications: • To address acute anxiety, Dr. Tufts prescribed a low dose of Ativan (0.5 mg) as needed. • She also prescribed Buspar (which Clancy was too afraid to start) and Hydroxyzine as a safer, non-habit-forming alternative to Ativan. Escalating Depressive Symptoms & Outside Care (December 2022) • Medication Instability: Although transitioning care, Clancy continued to schedule sporadic appointments with Dr. Tufts. On December 1, she reported that she was "not getting better" and was struggling with a rapid succession of medication changes prescribed by South Shore (including Trazodone, Prozac, Remeron, Klonopin, and Seroquel). On Remeron, she experienced intrusive thoughts of dying (though not active suicidal ideation). • Evaluation for Bipolar Disorder: Dr. Tufts assessed Clancy for bipolar disorder/mania due to her severe insomnia and poor medication tolerance, but concluded she did not meet the criteria as she lacked symptoms like euphoria, grandiosity, or pressured speech. Safety Interventions & Hospitalization Referrals: • On December 1, Dr. Tufts referred her to a partial hospitalization program (HRI in Brookline). • On December 16, following worsening depression and suicidal ideation (without active intent/plan) that led Clancy to visit the Mass General Hospital ER, Dr. Tufts prescribed low-dose Lamotrigine (Lamictal) and supported a referral to the specialized Women and Infants Program in Rhode Island. Final Clinical Phase (January 2023) • Post-Discharge from McLean Hospital: On January 6, 2023, Clancy met with Dr. Tufts after being admitted to and discharged from McLean Hospital, where she had gone to safely taper off Seroquel. She was on low doses of Trazodone, Ativan, and Melatonin. Dr. Tufts described Clancy's mood as "numb" and clinical condition as "deteriorating". • Rebound Anxiety & Diazepam Switch: Due to "rebound anxiety" occurring as Ativan wore off in the mornings, Dr. Tufts transitioned her to Diazepam (Valium), which has a longer half-life and is easier to taper gradually. • Ketamine Inquiry: Via email on January 11, Clancy asked about ketamine therapy, expressing desperation for a treatment that would work quickly. • Amitriptyline Prescription: On January 16, noting Clancy's flat affect and her statement that her maternal bonding felt "forced," Dr. Tufts prescribed a low starting dose (10 mg) of Amitriptyline to target both depression and insomnia. 00:00:00 - MA v Lindsay Clancy - Dr. Jennifer Tufts 00:00:14 - Direct Exam: Dr. Jennifer Tufts (Credentials & Care Timeline) 01:51:58 - Cross-Examination (Attorney Reddington) 02:22:49 - Edinburgh Scale & Screening Choices 03:09:17 - Suicidal Ideation vs. Worry About Suicide 03:34:20 - Remeron, Med Combinations & Hospital Programs 04:46:21 - Redirect Examination 05:21:21 - Recross & Pressured-Speech Chart Note Lindsay Clancy Trial Playlist:    • MA v Lindsay Clancy - Jury Selection Day 1